ENCYCLE THERAPEUTICS
Encycle Therapeutics is a Toronto-based biotech company exploiting a unique platform technology that enables the rapid synthesis of drug-like macrocycles or membrane-permeable nacellins. Nacellins have enormous potential to target intracellular protein-protein interactions, which are largely intractable to small molecule and biologic modulation, and can represent cheaper, oral equivalents to existing biologics (e.g., monoclonal antibodies). Encycle has collaborated with several pharmaceutical co... mpanies to complete a screening library of nacellins, many of which are cell-permeable and possess other drug-like properties. The company is also pursuing independent development of nacellins against integrin alpha-4-beta-7 (IBD) and SMURF2 (fibrosis); its lead program seeks to develop orally bioavailable inhibitors of integrin alpha-4-beta-7, which are safer and less immunogenic than marketed and investigational biologics targeting the same protein.
ENCYCLE THERAPEUTICS
Social Links:
Industry:
Biotechnology Chemical Therapeutics
Founded:
2012-01-01
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.encycletherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+1 (647) 258-4500
Email Addresses:
[email protected]
Total Funding:
6.07 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Wordpress Plugins
Current Advisors List
Current Employees Featured
Founder
Investors List
AcelRx Pharmaceuticals
AcelRx Pharmaceuticals investment in Venture Round - Encycle Therapeutics
BDC Capital Corporation
BDC Capital Corporation investment in Venture Round - Encycle Therapeutics
MaRS Investment Accelerator Fund
MaRS Investment Accelerator Fund investment in Venture Round - Encycle Therapeutics
Takeda Ventures
Takeda Ventures investment in Venture Round - Encycle Therapeutics
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners investment in Venture Round - Encycle Therapeutics
CQDM
CQDM investment in Venture Round - Encycle Therapeutics
Ontario Centres of Excellence
Ontario Centres of Excellence investment in Seed Round - Encycle Therapeutics
Ontario Centres of Excellence
Ontario Centres of Excellence investment in Grant - Encycle Therapeutics
Official Site Inspections
http://www.encycletherapeutics.com
- Host name: 104.207.141.197.vultrusercontent.com
- IP address: 104.207.141.197
- Location: Elk Grove Village United States
- Latitude: 42.0048
- Longitude: -87.9954
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60007
More informations about "Encycle Therapeutics"
Encycle Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +1 (647) 258-4500 Encycle Therapeutics is a Toronto-based biotech company exploiting a …See details»
Encycle Therapeutics Company Profile | Management and
Www.encycletherapeutics.com . Encycle Therapeutics Profile and History. Encycle Therapeutics is a drug discovery company that is exploiting a novel synthetic method to generate "nacellins," …See details»
Encycle Therapeutics - PitchBook
Encycle Therapeutics General Information Description. Developer of drugs designed to exploit a novel synthetic method to generate drug-like cyclic peptides. The company's drugs are …See details»
Encycle Therapeutics - Craft
Encycle Therapeutics has 5 employees at their 1 location and $4.63 m in total funding,. See insights on Encycle Therapeutics including office locations, competitors, revenue, financials, …See details»
Encycle Therapeutics - Overview, News & Similar companies
Encycle Therapeutics contact info: Phone number: (647) 258-4500 Website: www.encycletherapeutics.com What does Encycle Therapeutics do? Encycle Therapeutics is …See details»
Zealand Pharma acquisition Encycle Therapeutics | Gowling WLG
On October 22, 2019, Copenhagen-based Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78) announced its cross-border acquisition of Toronto-based Encycle …See details»
Andrei Yudin's Encycle Therapeutics acquired by Zealand Pharma
Oct 31, 2019 A drug discovery company started by Professor Andrei Yudin has been acquired by Zealand Pharma, a Copenhagen-based biotechnology company. Encycle Therapeutics was …See details»
Zealand Pharma acquires Encycle Therapeutics - BioTuesdays
Oct 24, 2019 Zealand Pharma (NASDAQ:ZEAL) of Denmark has acquired Encycle Therapeutics, a closely-held biotech company in Toronto, exploiting a unique platform …See details»
Zealand Pharma expands its peptide platform with acquisition of …
Oct 23, 2019 Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics. Wednesday, October 23, 2019 . Zealand Pharma A/S, a Copenhagen-based …See details»
Zealand Pharma to acquire Canada’s Encycle Therapeutics
The mode of action of the target has been validated in IBD by vedolizumab, an alpha-4-beta-7 integrin inhibitor. The terms of the agreement cover all rights to develop and commercialise …See details»
Zealand Pharma acquires Encycle - European Biotechnology …
Oct 23, 2019 Under the agreement, Zealand Pharma A/S will acquire all outstanding shares in Encycle Therapeutics Inc., and all its intellectual property, including methods for generation of …See details»
Encycle Wellness | Innovative Health Supplements for Your Well …
Nov 25, 2024 Discover Encycle Wellness, a trusted source for innovative health supplements designed to enhance your well-being. Get expert reviews and insights on cutting-edge …See details»
Zealand Pharma Completes Cross-Border Acquisition Of Encycle
On October 22, 2019, Copenhagen-based Zealand Pharma A/S ("Zealand") (NASDAQ: ZEAL) (CVR-no. 20 04 50 78) announced its cross-border acquisition...See details»
Encycle Therapeutics raises over $2.5 mln to advance drug platform
Nov 11, 2014 Biotechnology startup Encycle Therapeutics Inc recently secured more than $2.5 million from undisclosed investors. The capital infusion is intended to support the company's …See details»
Encycle Therapeutics - VentureRadar
Similar Companies: Aileron Therapeutics USA Publicly Traded Aileron Therapeutics is a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its …See details»
Encycle Therapeutics announces discovery collaboration with …
TORONTO, November 1, 2017 – Encycle Therapeutics (“Encycle”), a Toronto-based drug discovery company built on a unique chemistry that enables the synthesis of a new type of …See details»
Encycle Therapeutics travaillera avec de grandes sociétés ...
Jun 16, 2015 Le CQDM et MaRS Innovation investissent dans ce nouveau projet d'Encycle afin d'établir des règles sur la façon de rendre des peptides thérapeutiquesSee details»
Encycle Therapeutics announces discovery collaboration with
Nov 1, 2017 Contact Data Jeffrey Coull Encycle Therapeutics Inc 647-255-1304 [email protected]See details»
Encycle Therapeutics working with major pharmaceutical …
Jun 16, 2015 CQDM and MaRS Innovation investing in new Encycle project to determine rules for making peptide drugs orally bioavailable, a biotechnology company founded bySee details»